Clinical Trial Update: Omics of Rituximab-resistance

View source ↗

Summary

A clinical trial update describes an omics study investigating Rituximab resistance in membranous nephropathy, sponsored by Mario Negri Institute, currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Membranous Nephropathy | Status: NOT_YET_RECRUITING